Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.

@article{Charlton2013FactorsAW,
  title={Factors associated with use of preoperative chemoradiation therapy for rectal cancer in the Cancer Care Outcomes Research and Surveillance Consortium.},
  author={Mary E Charlton and Chi Lin and Dingfeng Jiang and Karyn Beth Stitzenberg and Thorvardur Ragnar Halfdanarson and Jane Pendergast and Elizabeth A. Chrischilles and Robert B. Wallace},
  journal={American journal of clinical oncology},
  year={2013},
  volume={36 6},
  pages={
          572-9
        }
}
PURPOSE Preoperative (preop) chemoradiation therapy (CRT) improves local control and reduces toxicity more than postoperative (postop) CRT for the treatment of stages II/III rectal cancer, but studies suggest that many patients still receive postop CRT. We examined patient beliefs and clinical and provider characteristics associated with receipt of recommended therapy. METHODS We identified stages II/III rectal cancer patients who had primary site resection and CRT among subjects in the… CONTINUE READING
BETA
3
Twitter Mentions

Similar Papers